Literature DB >> 24770567

Successful domino liver transplantation in maple syrup urine disease using a related living donor.

F H Feier1, I K Miura1, E A Fonseca1, G Porta1, R Pugliese1, A Porta1, I V D Schwartz2, A V B Margutti3, J S Camelo3, S N Yamaguchi4, A T Taveira5, H Candido1, M Benavides1, V Danesi1, T Guimaraes1, M Kondo1, P Chapchap1, J Seda Neto1.   

Abstract

Maple syrup urine disease (MSUD) is an autosomal recessive disease associated with high levels of branched-chain amino acids. Children with MSUD can present severe neurological damage, but liver transplantation (LT) allows the patient to resume a normal diet and avoid further neurological damage. The use of living related donors has been controversial because parents are obligatory heterozygotes. We report a case of a 2-year-old child with MSUD who underwent a living donor LT. The donor was the patient's mother, and his liver was then used as a domino graft. The postoperative course was uneventful in all three subjects. DNA analysis performed after the transplantation (sequencing of the coding regions of BCKDHA, BCKDHB, and DBT genes) showed that the MSUD patient was heterozygous for a pathogenic mutation in the BCKDHB gene. This mutation was not found in his mother, who is an obligatory carrier for MSUD according to the family history and, as expected, presented both normal clinical phenotype and levels of branched-chain amino acids. In conclusion, our data suggest that the use of a related donor in LT for MSUD was effective, and the liver of the MSUD patient was successfully used in domino transplantation. Routine donor genotyping may not be feasible, because the test is not widely available, and, most importantly, the disease is associated with both the presence of allelic and locus heterogeneity. Further studies with this population of patients are required to expand the use of related donors in MSUD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770567      PMCID: PMC4086180          DOI: 10.1590/1414-431x20143830

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  20 in total

1.  Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience.

Authors:  George V Mazariegos; D Holmes Morton; Rakesh Sindhi; Kyle Soltys; Navdeep Nayyar; Geoffrey Bond; Diana Shellmer; Benjamin Shneider; Jerry Vockley; Kevin A Strauss
Journal:  J Pediatr       Date:  2011-08-11       Impact factor: 4.406

Review 2.  Lessons from genetic disorders of branched-chain amino acid metabolism.

Authors:  David T Chuang; Jacinta L Chuang; R Max Wynn
Journal:  J Nutr       Date:  2006-01       Impact factor: 4.798

3.  Modified pediatric end-stage liver disease scoring system and pediatric liver transplantation in Brazil.

Authors:  Joao Seda Neto; Eduardo Carone; Renata P S Pugliese; Eduardo A Fonseca; Gilda Porta; Irene Miura; Vera B Danesi; Teresa C Guimaraes; Andre L Godoy; Adriana Porta; Rodrigo Vincenzi; Francisco Carnevale; Mario Kondo; Paulo Chapchap
Journal:  Liver Transpl       Date:  2010-04       Impact factor: 5.799

4.  Living donor liver transplantation for noncirrhotic inheritable metabolic liver diseases: impact of the use of heterozygous donors.

Authors:  Daisuke Morioka; Yasutsugu Takada; Mureo Kasahara; Takashi Ito; Kenji Uryuhara; Kohei Ogawa; Hiroto Egawa; Koichi Tanaka
Journal:  Transplantation       Date:  2005-09-15       Impact factor: 4.939

5.  Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series.

Authors:  D A Shellmer; A DeVito Dabbs; M A Dew; R B Noll; H Feldman; K A Strauss; D H Morton; J Vockley; G V Mazariegos
Journal:  Pediatr Transplant       Date:  2010-10-08

6.  Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease.

Authors:  B Zhang; H J Edenberg; D W Crabb; R A Harris
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.

Authors:  M Tsuruta; H Mitsubuchi; S Mardy; Y Miura; Y Hayashida; A Kinugasa; T Ishitsu; I Matsuda; Y Indo
Journal:  J Hum Genet       Date:  1998       Impact factor: 3.172

8.  Detection of heterozygotes in maple-syrup-urine disease: measurements of branched-chain alpha-ketoacid dehydrogenase and its components in cell cultures.

Authors:  D T Chuang; L S Ku; D S Kerr; R P Cox
Journal:  Am J Hum Genet       Date:  1982-05       Impact factor: 11.025

9.  Variant maple syrup urine disease in mother and daughter.

Authors:  L A Zaleski; J Dancis; R P Cox; J Hutzler; W A Zaleski; A Hill
Journal:  Can Med Assoc J       Date:  1973-08-18       Impact factor: 8.262

10.  [Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment].

Authors:  J C Netter; G Cossarizza; C Narcy; P Hubert; H Ogier; Y Revillon; D Rabier; J M Saudubray
Journal:  Arch Pediatr       Date:  1994-08       Impact factor: 1.180

View more
  9 in total

Review 1.  Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.

Authors:  Kimihiko Oishi; Ronen Arnon; Melissa P Wasserstein; George A Diaz
Journal:  Pediatr Transplant       Date:  2016-06-21

2.  Acute Metabolic Crises in Maple Syrup Urine Disease After Liver Transplantation from a Related Heterozygous Living Donor.

Authors:  Aisha Al-Shamsi; Alastair Baker; Anil Dhawan; Jozef Hertecant
Journal:  JIMD Rep       Date:  2016-04-28

3.  Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.

Authors:  Neslihan Celik; Beau Kelly; Kyle Soltys; James E Squires; Jerry Vockley; Diana A Shellmer; Kevin Strauss; Patrick McKiernan; Armando Ganoza; Rakesh Sindhi; Geoffrey Bond; George Mazariegos; Ajai Khanna
Journal:  Clin Transplant       Date:  2019-10-06       Impact factor: 2.863

4.  Molecular basis of various forms of maple syrup urine disease in Chilean patients.

Authors:  Diana Ruffato Resende Campanholi; Ana Vitoria Barban Margutti; Wilson A Silva; Daniel F Garcia; Greice A Molfetta; Adriana A Marques; Ida Vanessa Döederlein Schwartz; V Cornejo; Valerie Hamilton; Gabriela Castro; Fernanda Sperb-Ludwig; Ester S Borges; José S Camelo
Journal:  Mol Genet Genomic Med       Date:  2021-05-06       Impact factor: 2.183

5.  Natural history of children and adults with maple syrup urine disease in the NBS-MSUD Connect registry.

Authors:  Aileen Kenneson; Yetsa Osara; Theresa Pringle; Lauren Youngborg; Rani H Singh
Journal:  Mol Genet Metab Rep       Date:  2018-01-28

6.  Information and Diagnosis Networks - tools to improve diagnosis and treatment for patients with rare genetic diseases.

Authors:  Taiane Alves Vieira; Franciele Barbosa Trapp; Carolina Fischinger Moura de Souza; Lavínia Schuler Faccini; Laura Bannach Jardim; Ida Vanessa Doederlein Schwartz; Mariluce Riegel; Carmen Regla Vargas; Maira Graeff Burin; Sandra Leistner-Segal; Patrícia Ashton-Prolla; Roberto Giugliani
Journal:  Genet Mol Biol       Date:  2019-06-10       Impact factor: 1.771

7.  Maple syrup urine disease in Brazilian patients: variants and clinical phenotype heterogeneity.

Authors:  Ana Vitoria Barban Margutti; Wilson Araújo Silva; Daniel Fantozzi Garcia; Greice Andreotti de Molfetta; Adriana Aparecida Marques; Tatiana Amorim; Vânia Mesquita Gadelha Prazeres; Raquel Tavares Boy da Silva; Irene Kazue Miura; João Seda Neto; Emerson de Santana Santos; Mara Lúcia Schmitz Ferreira Santos; Charles Marques Lourenço; Tássia Tonon; Fernanda Sperb-Ludwig; Carolina Fischinger Moura de Souza; Ida Vanessa Döederlein Schwartz; José Simon Camelo
Journal:  Orphanet J Rare Dis       Date:  2020-11-01       Impact factor: 4.123

8.  Nutrient management in the intrapartum period in maternal maple syrup urine disease.

Authors:  Chika Takano; Mika Ishige; Erika Ogawa; Nobuhiko Nagano; Tamaki Morohashi; Aya Okahashi; Kaori Kawakami; Atsushi Komatsu; Kei Kawana; Tatsuhiko Urakami; Ichiro Morioka
Journal:  Mol Genet Metab Rep       Date:  2021-01-29

9.  Two consecutive partial liver transplants in a patient with Classic Maple Syrup Urine Disease.

Authors:  H L Chin; M M Aw; S H Quak; J Huang; C E Hart; K Prabhakaran; D L Goh
Journal:  Mol Genet Metab Rep       Date:  2015-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.